Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
This randomized phase III trial studies whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence).
This randomized controlled trial of weight loss interventions in overweight and obese women with early stage breast cancer consists of two arms. The purpose of this study is to compare the effect of the telephone-based intervention versus a health educational control on invasive disease-free survival (IDFS).
- IRB Number: 1610745694 (A011401)
- Research Study Identifier: TX7114
- Principal Investigator: Kathy Miller, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required